Both in Pharmaceuticals
Vyome Holdings vs AEON Biopharma
Over the past year HIND returned −69.2% and AEON returned −72.7%; their daily moves had a correlation of -0.04.
HIND −69.2% AEON −72.7%Growth of $1, one year, split-adjusted
| Metric | HIND | AEON |
|---|---|---|
| Price | $1.70 | $0.2483 |
| Market cap | $11.9M | $12.4M |
| Today | −0.58% | +3.46% |
| 1 month | −16.3% | −5.1% |
| 6 months | −19.0% | −74.8% |
| Year to date | −50.6% | −77.4% |
| 1 year | −69.0% | −73.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | 43.2% | — |
| Net margin | −2543.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 92.0× | — |
| Net cash | $7.9M | $743.0K |
| Dividend yield | — | — |
| Volatility (60d) | 40.7% | 113.7% |
| Short % of float | 1.2% | 28.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).